| $385M | ||
| $350M | ||
| $215M | ||
| $94M | ||
| $82M | ||
| $62M |
Buys | $3,857,304 | 21 | 100 |
Sells | $0 | 0 | 0 |
| Opaleye Management Inc. | 10 percent owner | 21 | $3.86M | 0 | $0 | $3.86M |
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris; Epsolay, a once-daily topical cream that has completed Phase III clinical trials for the treatment of papulopustular rosacea; SGT-210, which is in Phase I clinical trial for the treatment of palmoplantar keratoderma; and Erlotinib, Tapinarof, and roflumilast to treat psoriasis and other medical conditions. It is also involved in the development of generic topical dermatological drug products. The company has collaboration with Perrigo. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
Over the last 12 months, insiders at Sol-Gel Technologies Ltd. have bought $3.86M and sold $0 worth of Sol-Gel Technologies Ltd. stock.
On average, over the past 5 years, insiders at Sol-Gel Technologies Ltd. have bought $3.86M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Opaleye Management Inc. (10 percent owner) — $3.86M.
The last purchase of 100 shares for transaction amount of $5,800 was made by Opaleye Management Inc. (10 percent owner) on 2026‑02‑02.
| 2026-02-02 | Opaleye Management Inc. | 10 percent owner | 100 0.0031% | $58.00 | $5,800 | +12.41% | ||
| 2026-01-27 | Opaleye Management Inc. | 10 percent owner | 100 0.0035% | $57.05 | $5,705 | +10.75% | ||
| 2026-01-23 | Opaleye Management Inc. | 10 percent owner | 1,151 0.0396% | $55.98 | $64,434 | +8.05% | ||
| 2026-01-22 | Opaleye Management Inc. | 10 percent owner | 2,173 0.0767% | $56.57 | $122,922 | -1.52% | ||
| 2026-01-05 | Opaleye Management Inc. | 10 percent owner | 198 – | $42.98 | $8,510 | +42.34% | ||
| 2026-01-02 | Opaleye Management Inc. | 10 percent owner | 2,394 – | $41.92 | $100,348 | +49.05% | ||
| 2025-12-31 | Opaleye Management Inc. | 10 percent owner | 22,497 0.7228% | $41.99 | $944,744 | +48.91% | ||
| 2025-12-30 | Opaleye Management Inc. | 10 percent owner | 35,169 1.1298% | $41.99 | $1.48M | +47.65% | ||
| 2025-12-29 | Opaleye Management Inc. | 10 percent owner | 8,638 0.2766% | $41.85 | $361,534 | +40.62% | ||
| 2025-12-26 | Opaleye Management Inc. | 10 percent owner | 1,626 0.0518% | $41.68 | $67,765 | +48.08% | ||
| 2025-12-23 | Opaleye Management Inc. | 10 percent owner | 260 0.0083% | $41.66 | $10,832 | +40.16% | ||
| 2025-12-22 | Opaleye Management Inc. | 10 percent owner | 1,019 0.0321% | $41.15 | $41,936 | +41.60% | ||
| 2025-12-17 | Opaleye Management Inc. | 10 percent owner | 2,735 0.0845% | $40.37 | $110,412 | +40.38% | ||
| 2025-12-12 | Opaleye Management Inc. | 10 percent owner | 87 0.0027% | $40.00 | $3,480 | +46.12% | ||
| 2025-12-08 | Opaleye Management Inc. | 10 percent owner | 300 0.0091% | $39.77 | $11,933 | +25.98% | ||
| 2025-12-05 | Opaleye Management Inc. | 10 percent owner | 444 0.0134% | $39.50 | $17,537 | +22.10% | ||
| 2025-12-03 | Opaleye Management Inc. | 10 percent owner | 2,524 0.073% | $37.81 | $95,443 | +15.59% | ||
| 2025-12-01 | Opaleye Management Inc. | 10 percent owner | 4,340 0.1241% | $37.37 | $162,167 | +17.02% | ||
| 2025-11-26 | Opaleye Management Inc. | 10 percent owner | 943 0.0289% | $40.00 | $37,720 | +9.03% | ||
| 2025-11-24 | Opaleye Management Inc. | 10 percent owner | 6 0.0002% | $35.50 | $213 | +5.03% |
| Increased Positions | 3 | +18.75% | 213,719 | +32.82% |
| Decreased Positions | 6 | -37.5% | 427,807 | -65.7% |
| New Positions | 3 | New | 213,719 | New |
| Sold Out Positions | 3 | Sold Out | 150,994 | Sold Out |
| Total Postitions | 13 | -18.75% | 437,020 | -32.88% |